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Environmental chemicals may be involved in
the etiology of breast cancers. Many human
tumors have been causally attributed to
exposure to environmental carcinogens, pol-
lutants, pesticides, drugs, ultraviolet light,
radiation, and tobacco (1). The incidence of
breast tumors in women is increasing, and
environmental chemicals have been partially
implicated in this increase (2). In vivo and in
vitro data have shown that environmental
substances (e.g., DDT, polychlorinated
biphenyls, 4-nonylphenol, 4-octylphenol)
can promote mammary cancer (3,4).
The toxic effect of organophosphorous
insecticides, which represent a major class of
agricultural chemicals, is to conjugate with
the natural complement of cholinesterase
enzymes in the body, thereby inactivating
them. Parathion [0,0-diethyl 0-(4-nitro-
phenyl)-phosphorothyoate] and malathion
[0,0-dimethyl S-(1,2-dicarbethoxy-ethyl)-
phosphorodithioate] are organophosphorous
pesticides that are extensively used to control
a wide range of sucking and chewing pests of
ﬁeld crops, fruits, and vegetables. They have
structural similarities with naturally occur-
ring compounds, and their primary target of
action in insects is the nervous system.
Malathion is also present in lotions and
shampoos marketed for the treatment of
head lice and mites in humans. Exposure of
the skin to these two pesticides has been
shown to result in a small amount of sys-
temic absorption (5,6). 
Eserine [(3α ,S-cis)-1,2,3,3α ,8,8α -
Hexahydro-1,3α ,8-trimethylpyrrolo (2,3-b)
indol-5-ol methylcarbamate] is an ester
obtained from calabar beans, the seeds of the
vine Physostigma venenosum. It is used as a
miotic drug and for atony of gastrointestinal
tract, but it is very toxic if inhaled or swal-
lowed (5). Eserine, as well as parathion and
malathion, is incorporated through the epithe-
lium of the skin, mouth, and respiratory tract
(5,6). In the liver, parathion and malathion
are activated by enzymatic processes produc-
ing paraoxon and malaoxon, respectively
(5,6). Eserine, parathion, and malathion are
acetylcholinesterase (AchE) inhibitors and
are responsible for the hydrolysis of body
choline esters, including acetylcholine (Ach)
at cholinergic synapses (5–7). The inhibition
of these enzymes increases the availability of
Ach, which in turn can stimulate cholinergic
receptors producing both nicotinic and mus-
carinic effects in the organism such as mus-
cle contractions and secretions in many
glands (5). Atropine is a parasympatholytic
alkaloid used as an antidote to AchE
inhibitors (5,6); it acts through competitive
occupation of nicotinic and muscarinic
cholinergic receptors (8).
The high level of cell proliferation and
differentiation that occurs during mammary
gland development makes this organ an
attractive experimental animal model for
examining its susceptibility to different car-
cinogenic actions. Cell proliferation in the
mammary gland is not a random event, but
is intimately related to both topography of
the mammary parenchyma and specific
stages of the gland development that are
modulated by age, hormonal variations, and
parity history. Different compartments, such
as ducts, ductules, and intralobular terminal
ducts, have been observed in rats. The
intralobular terminal duct is equivalent to
the terminal ductal lobular unit in the
human breast, considered the site of origin
of human breast carcinomas (9–14).
The mammary gland is a complex organ
that undergoes continuous changes under
the influence of body growth as well as
cyclic hormonal stimulation from birth to
senescence. Under these influences, the
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Articles
Environmental chemicals may be involved in the etiology of breast cancers. Many studies have
addressed the association between cancer in humans and agricultural pesticide exposure.
Organophosphorous pesticides have been used extensively to control mosquito plagues. Parathion
and malathion are organophosphorous pesticides extensively used to control a wide range of suck-
ing and chewing pests of ﬁeld crops, fruits, and vegetables. They have many structural similarities
with naturally occurring compounds, and their primary target of action in insects is the nervous
system; they inhibit the release of the enzyme acetylcholinesterase at the synaptic junction.
Eserine, parathion, and malathion are cholinesterase inhibitors responsible for the hydrolysis of
body choline esters, including acetylcholine at cholinergic synapses. Atropine, a parasympa-
tholytic alkaloid, is used as an antidote to acetylcholinesterase inhibitors. The aim of this study
was to examine whether pesticides were able to induce malignant transformation of the rat mam-
mary gland and to determine whether alterations induced by these substances increase the cholin-
ergic activation influencing such transformation. These results showed that eserine, parathion,
and malathion increased cell proliferation of terminal end buds of the 44-day-old mammary gland
of rats, followed by formation of 8.6, 14.3, and 24.3% of mammary carcinomas, respectively,
after about 28 months. At the same time, acetylcholinesterase activity decreased in the serum of
these animals from 9.78 ± 0.78 U/mL in the control animals to 3.05 ± 0.06 U/mL; 2.57 ± 0.15
U/mL; and 3.88 ± 0.44 U/mL in the eserine-, parathion-, and malathion-treated groups, respec-
tively. However, atropine alone induced a significant (p < 0.05) decrease in the acetyl-
cholinesterase activity from the control value of 9.78 ± 0.78 to 4.38 ± 0.10 for atropine alone, to
1.32 ± 0.06 for atropine in combination with eserine, and 2.39 ± 0.29 for atropine with
malathion, and there was no mammary tumor formation. These results indicate that organophos-
phorous pesticides induce changes in the epithelium of mammary gland inﬂuencing the process of
carcinogenesis, and such alterations occur at the level of nervous system by increasing the cholin-
ergic stimulation. Key words: acetylcholinesterase, atropine, malathion, parathion, rat mammary
cancer. Environ Health Perspect 109:471–479 (2001). [Online 3 May 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p471-479cabello/abstract.htmlhistology of the gland becomes extremely
heterogeneous. The rat mammary glands are
distributed in pairs along the milk line, with
one pair located in the cervical, two pairs in
the thoracic, one in the abdominal, and two
in the inguinal region. The basic develop-
ment of all the glands follows a uniform pat-
tern, and previous studies (9) have established
criteria for evaluating mammary growth,
development and differentiation. With such
criteria, the mammary parenchyma is divided
into thirds along the longitudinal axis. The
third closest to the nipple, called zone A, is
composed of the main lactiferous ducts. The
intermediate area, called zone B, contains
more abundant lateral buds, and it is in this
area where most of the secondary ducts
arise. The distal third of the gland, or zone
C, contains the terminal structures ending
in bulbous clubs or terminal end buds
(TEBs) (9). The mammary gland is com-
posed of a single primary or main lactiferous
duct that branches into three to five sec-
ondary ducts at birth and during the first
week of postnatal life. The ducts are narrow
and straight and end in small, club-shaped
terminals, the TEBs. During the second
week, further sprouting of ducts occurs up
to the sixth cell generation. This sprouting
of ducts causes a marked increase in the
density of TEBs, which reaches its maxi-
mum magnitude when the animal is 21 days
old (9). Histologically, TEBs are composed
of three to six layers of medium-sized
epithelial cells. After the rat reaches 21 days
of age, further sprouting of lateral buds
occurs, and numerous TEBs begin to cleave
into three to five smaller buds, the alveolar
buds (ABs). The differentiation of the mam-
mary gland induces a progressive decrease in
the number of TEBs and a concomitant
increase in the number of ABs (9–13).
The crucial role that topography plays in
susceptibility of the breast to carcinogenesis
in young nulliparous rats involves the pres-
ence of TEBs. The TEBs are the most highly
proliferating structures in the breast and
therefore are the most susceptible to neoplas-
tic transformation (9–13). The study of the
pathogenesis of mammary cancer in experi-
mental models has shown that the suscepti-
bility of the mammary gland to chemical
carcinogenesis is directly related to the rate
of cell proliferation of the glandular epithe-
lium at the time of the exposure to the car-
cinogen (11). 
The most widely used experimental
systems for the study of mammary tumorige-
nesis are the models in which tumors are
induced in the Sprague-Dawley rat by
dimethylbenz[α ]anthracene (DMBA)
(15–17) or in the Sprague-Dawley or Fischer
344 rat by N-nitrosomethylurea (NMU)
(18). The administration of DMBA to virgin
rats of different ages induced tumors with an
incidence that was directly proportional to the
density of highly proliferative TEBs (12).
Tumor incidence of 94–100% was obtained
when DMBA was administered to rats 30–55
days of age; but the highest number of tumors
per animal was observed when the carcinogen
was given to animals when they were 40–46
days of age—a period when TEBs were most
actively differentiating into ABs (9–13).
Many studies have addressed the associa-
tion between cancer in humans and agricul-
tural pesticide exposure, both occupational
(e.g., farmers, pesticides mixers, and appli-
ers) and nonoccupational. Nonoccupational
exposures occur in farmers exposed to pesti-
cides stored in homes, contaminated cloth-
ing, household dust containing pesticides,
contaminated ground and surface water,
contaminated soil, and drift from aerial
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Figure 1. Structures of a normal rat mammary gland composed of a main lactiferous duct (A; 350× ), which
begin to cleave into smaller TEBs and ABs forming lobules (C). (B) Whole-mount preparation of represen-
tative TEBs. (D) Higher magnification of a lobule formed by ABs found in cross-section of (C).
Hematoxylin-eosin, 400× .
Figure 2. Whole-mount preparation of the abdominal (fourth pair) 21-day-old female rat mammary gland.
Presence of TEBs in (A) control, (B) eserine-, (C) parathion-, and (D) malathion-treated animals.
Hematoxylin-eosin, 400× .spraying of pesticides. Mortality and inci-
dence studies have reported slightly increased
rates for the following cancers: breast, non-
Hodgkin lymphoma, Hodgkin disease, mul-
tiple myeloma, leukemia, prostate, and ovary
(19–21).
Our purpose was to test the susceptibil-
ity of the mammary gland to organophos-
phorous pesticides. Therefore, we analyzed
whether eserine, parathion, and malathion
can induce mammary tumors in rats,
whether the alterations induced by these
substances alter the cholinergic activation
inﬂuencing malignant transformation of the
mammary gland, and whether such action
can be inhibited by a parasympatholytic
alkaloid, such as atropine.
Materials and Methods
Female Sprague-Dawley rats were obtained
from the Catholic University of Chile
(Santiago, Chile). These animals were
housed and bred in a barrier animal facility
operated in accordance with the standards
outlined in Guide for the Care and Use of
Laboratory Animals (22). All animals were
allowed continuous access to a standard
laboratory chow diet (Champion, Santiago,
Chile). The ﬁrst experiment was performed
with 35 virgin female Sprague-Dawley rats
16 days old. Seven groups of five animals
received injections twice a day for 5 days
subcutaneously (sc) or intraperitoneally (ip)
in the inguinal region of the body. Animals
were injected with one of the following
subtances: saline solution (sc); eserine (sc;
Sigma, St. Louis, MO, USA), 33 µg/100 g
body weight (bw); parathion (sc; Bayer,
Santiago, Chile), 250 µg/100 g bw; malathion
(sc; Fyfanon TM, Cheminova, Denmark), 17
mg/100 g bw; atropine (ip; Sigma), 250
µg/100 g bw; combination of eserine and
atropine; and combination of malathion and
atropine at the dosages previously indicated.
The LD50 values of the substances for eser-
ine, parathion, and malathion were 0.64, 3.6,
and 1,000 mg/kg, respectively. However, the
doses used in these experiments were one-half
the LD50 for eserine and parathion and one-
sixth the LD50 for malathion, which allowed
a 100% survival of animals after 5-day
treatment.
The second experiment was performed
under identical conditions but the experi-
ment started when the animals were 39 days
old. Sixteen hours after the last injections,
the animals from these two experimental
designs were anesthetized by ip injections of
sodium pentobarbital (8 mg/100 g bw) and
opened by a midline incision from the pubis
to the submaxillary area to remove the mam-
mary glands. The skin was dissected to
expose the six pairs of mammary glands, the
thoracic, abdominal, and inguinal mammary
glands. The left side of control and treated
rats was prepared for whole-mount prepara-
tion and the right side for histologic studies. 
Mammary glands for the whole-mount
studies were ﬁxed in alcohol, formaldehyde,
and acetic acid (1:1:1) for 24 hr at room tem-
perature, stained with hematoxylin-eosin,
and mounted between two slides to visualize
under a Zeiss Video Plan (Chicago, IL, USA)
(10). The mammary gland of rats is suffi-
ciently ﬂat to allow the determination of the
area and the quantification of structures in
areas of 1 mm2. We counted 50 areas located
mainly distal to the nipple in each gland, and
we counted the density of TEBs and ABs in
these whole-mount preparations. The density
of these structures was expressed in number
of structures per square millimeter. To deter-
mine the histology, we fixed the glands in
Bouin’s fixative and embedded them in
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Figure 3. Histologic section of TEBs of the mammary gland from the control and 21-day-old treated female rats. Presence of TEBs in (A) control, (B) eserine-, (C)
parathion-, and (D) malathion-treated animals. Hematoxylin-eosin, 400× .parafﬁn. The glands were oriented ﬂat so that
the parallel sections corresponded with the
whole-mount preparation. Then the glands
were serially sectioned at a thickness of 5 µm
and stained with hematoxylin-eosin.
Histomorphometry was performed using a
Bausch & Lomb (Rochester, NY, USA)
binocular microscope, in which a 1-mm2
grid was installed in one of the oculars. The
measurements were done with 10× ocular.
We counted ﬁve slides per animal to deter-
mine the number of TEBs and ABs in the
mammary gland from control and treated
animals. A total of 20 areas of 1 mm2 were
counted in each gland. The data are
expressed as average ± standard error (SE) of
the mean.
We used blood extracted directly from
the heart of the animals to determine the
AchE activity in the serum. Whole blood
was centrifuged at 2,500 cycles per min;
serum was analyzed with the Caraway spec-
trophotometric method in the presence of
0.1 mM ethopropazine (Sigma), a substance
that inhibits butyrylcholinesterase activity
(23). One unit of activity is equal to 1 µmol
of substrate breakdown at 25°C. The results
are expressed as average ± standard error of
the mean. Statistical analysis was performed
with the F-test and all pairwise multiple
comparison procedures (Tukey t-test)
between groups with signiﬁcance at the p <
0.05 level.
The third experiment was performed with
560 virgin female rats at 39 days of age. Eight
groups of 70 animals each received sc injec-
tions (except for atropine, which was given ip
twice a day for 5 days) in the inguinal region
of one of the following substances: saline
solution; eserine; parathion; malathion;
atropine; combination of eserine and
atropine; and combination of malathion and
atropine at dosages previously indicated. All
the animals were housed three per cage for
28 months and were palpated weekly to
detect formation of tumors. After a tumor
was detected, the data were recorded and
tumors were allowed to develop for 1
month. After that time the animals were sac-
riﬁced. Palpable tumors were removed from
the animal, fixed with Bouin’s fluid, and
embedded in parafﬁn. The blocks were sec-
tioned at a thickness of 5 µm. Deparafﬁnized
sections were stained with hematoxylin-
eosin, and the tumors were analyzed under
the microscope as previously described
(9,14).
Results
The structure of a normal rat mammary
gland is composed of a single primary or
main lactiferous duct that branches into
secondary ducts from which TEBs and the
alveolar buds (ABs) are formed. The ducts
are narrow and straight and end in small,
club-shaped terminal structures, the TEBs
(Figure 1A,B), composed of three to six lay-
ers of medium-sized epithelial cells from
which numerous TEBs begin to cleave into
smaller buds, the ABs from which lobules are
formed (Figure 1C,D). Analysis of normal
rat mammary glands indicates that density of
TEBs (number of TEBs per square millime-
ter) increased steadily after birth and reached
its maximum value when animals were 21
days of age. A 21-day-old rat mammary
gland is made up mainly of TEBs. Figure 2
shows the presence of TEBs and absence of
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Table 1. Effect of eserine, parathion, malathion, and atropine on density of TEBs and ABs of 21-day-old
female Sprague-Dawley rat mammary glands (mean ± SE, n = 5)
Treatment TEBs/mm2 AB/mm2
Control 9.06 ± 0.97 0.06 ± 0.05
Eserine  7.49 ± 0.93 0.00 ± 0.00
Parathion 7.53 ± 0.30 0.00 ± 0.00
Malathion 7.08 ± 0.37 0.00 ± 0.00
Atropine 9.44 ± 0.90 0.00 ± 0.00
Atropine + eserine 9.80 ± 1.90 0.00 ± 0.00
Atropine + malathion 10.14 ± 1.80 0.00 ± 0.00
Density of TEBs and ABs of mammary gland of whole-mount preparations of animals that received twice a day for 5 days
injections of saline (control); 33 µg of eserine; 250 µg parathion; 17 mg malathion; 250 µg atropine; or combinations of
atropine + eserine or atropine + malathion per 100 g body weight. There was no signiﬁcant difference in TEBs or ABs
between control animals and those treated with eserine, parathion, malathion, atropine, atropine + eserine, or atropine +
malathion. 
Figure 4. Whole-mount preparation of the mammary gland of 44-day-old animals. It shows the presence of
ABs in (A) control, and the presence of TEBs in the (B) eserine-, (C) parathion-, and (D) malathion-treated
animals. Hematoxylin-eosin, 400× . 
Table 2. Effect of eserine, parathion, malathion, atropine, and combination of either atropine + eserine or
atropine + malathion on density of TEBs and ABs of 44-day-old female Sprague-Dawley rat mammary
glands (means ± SE, n = 5)
Treatment TEBs/mm2 AB/mm2
Control (saline) 3.30 ± 0.27 20.80 ± 1.68
Eserine (33 µg/100 g bw) 11.13 ± 1.67 0.75 ± 0.44
Parathion (250 µg/100 g bw) 12.04 ± 1.77 1.28 ± 0.52
Malathion (17 mg/100 g bw) 11.26 ± 0.48 2.50 ± 0.56
Atropine (250 µg/100 g bw) 3.48 ± 0.42  5.60 ± 0.57
Atropine + eserine 4.50 ± 0.75a 16.00 ± 0.80b
Atropine + malathion 1.82 ± 0.43a 14.96 ± 1.35b
Density of TEBs and ABs in whole-mount preparations of animals that received injections twice a day for 5 days. TEBs: p
< 0.05: control versus eserine, parathion, and malathion. TEBs: p < 0.05: Eserine versus atropine + eserine and malathion
versus atropine + malathion. 
aTEBs: nonsigniﬁcant: atropine versus atropine + eserine and versus atropine + malathion. ABs: p < 0.05: control versus
eserine, parathion, malathion, and atropine. bABs: nonsigniﬁcant: control versus atropine + eserine or atropine + malathion. ABs in the control (Figure 2A ), eserine-
(Figure 2B), parathion- (Figure 2C), and
malathion- (Figure 2D) treated 21-day-old
animals. Figure 3 shows a cross-section of
mammary glands of the same animals, which
corroborated the presence of TEBs in the
control (Figure 3A), eserine- (Figure 3B),
parathion- (Figure 3C), and malathion-
(Figure 3D) treated animals. These results
indicated that there was no signiﬁcant differ-
ence in the density of TEBs per square mil-
limeter of mammary gland between either
the control or the eserine-, parathion-, and
malathion-treated 21-day-old rats, and that
ABs were absent in the control as well as in
the treated animals (Table 1).
Whole-mount preparations in 44-day-
old rats showed a signiﬁcant (p < 0.05) dif-
ference in the density of TEBs and ABs
between control (Figure 4A) and treated ani-
mals (Figure 4B–D). Table 2 shows that
treatment with eserine and the pesticides
parathion and malathion induced a signifi-
cant increase (p < 0.05) in the density of
TEBs in the 44-day-old animals. The TEB
density increased from 3.30 ± 0.27
TEBs/mm2 to a maximum of 12.04 ± 1.77
TEBs/mm2 in parathion-treated animals
(Table 2). The AB density decreased in
treated animals from 20.80 ± 1.68 AB/mm2
in controls to a minimum of 0.75 ± 0.44
AB/mm2 in eserine-treated animals (Table
2). Parathion- and malathion-treated ani-
mals also showed a significant (p < 0.05)
decrease in the density of ABs. A representa-
tive whole-mount preparation of a 44-day-
old rat mammary gland of control animals
and a schematic representation of ABs are
presented in Figure 5A and B, respectively.
Representative whole-mount preparation
from a pesticide-treated rat mammary gland
and a schematic representation of such struc-
tures, which gives an overview of TEBs, are
shown in Figures 5C and D, respectively. 
Histologic examination of mammary tis-
sue of 44-day-old control and treated rats
supported the results seen with the whole-
mount preparation. The control rats had
normal lobule formation and presence of
ABs, whereas no ABs were observed in any
group of treated animals (Figure 6A–D).
The eserine-, parathion-, and malathion-
treated animals showed a significant (p <
0.05) increase in the size of TEBs of the
mammary gland, as well as in the number of
the epithelial layers (Figure 6B–D). Further-
more, such structures increased in size until
tumors started to appear. However, after
840 days the control animals did not
develop any kind of tumors. After pesticide
injections, treated animals developed tumors
at a rate of 8.6–24.3%. Table 3 shows the
number, size, and latency of these tumors
after 28 months of treatment. Among the
560 animals used in this experiment, 6 out
of 70 eserine-treated animals, 10 out of 70
parathion-treated animals, and 17 out of 70
malathion-treated animals developed mam-
mary tumors. Tumor size ranged from 9.26
± 3.43 to 22.1 ± 7.2 cm3. The malathion-
treated group had smaller tumors, but they
appeared earlier than with the other treat-
ments. The tumor latency range fluctuated
between 54 and 840 days. Treated animals
exhibited only mammary tumors that
appeared exclusively in the mammary fat pad
of the axillary and abdominal-inguinal
regions of the animal (Figure 7A,B).
Histologic diagnosis of the mammary
tumors revealed that they were adenocarci-
nomas, grossly nodular and encapsulated,
with areas of cribiform or papillary patterns
(Figure 7C, D). Most of the tumors devel-
oped in the abdominal region, with only one
tumor in the cervical region. Analysis of
lungs, heart, intestinal tract, ovaries, and
uterus did not show any tumors. Neurologic
symptoms that might have suggested tumors
of the nervous system were not observed.
Tables 1 and 2 also show the effect of
atropine either alone or in combination with
eserine or malathion on the density of struc-
tures present in the rat mammary glands.
Neither atropine nor the combination of
atropine with eserine or malathion induced
changes in the density of TEBs per square
millimeter in the mammary gland of 21-day-
old animals in comparison to control ani-
mals (Table 1). There was no significant
difference among these groups in comparison
to control animals. Table 2 shows the den-
sity of TEBs and ABs in the mammary gland
of 44-day-old animals treated with atropine
alone or in combination with the eserine or
malathion. Treatment of animals at this age
with atropine alone or in conjunction with
eserine or malathion did not induce any
change in the density of TEBs in compari-
son to the control animals (Figure 8A).
However, atropine caused a signiﬁcant (p <
0.05) inhibition of formation of ABs in these
animals compared to controls. Atropine
treatment in combination with either eserine
or malathion caused a signiﬁcant (p < 0.05)
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Figure 5. Whole-mount preparation of the mammary gland. (A) ABs; (B) a schematic representation of
these structures; (C) TEBS in pesticide-treated animals; and (D) an overview of (C). 400× .inhibition of density of TEBs in comparison
with the eserine, parathion, and malathion
alone. However, there was an increase in the
density of ABs similar to that of controls
(Figure 8B) and a significant (p < 0.05)
increase in the density of ABs in comparison
to animals treated with eserine, parathion,
and malathion. In addition, there was no rat
mammary tumor formation after the injec-
tion of atropine alone or with the combina-
tion of  atropine and eserine or malathion.
Figure 9 shows the correlation between the
density of TEBs and AchE activity in the
serum of the 44-day-old control and treated
animals. These results showed a significant
(p < 0.05) decrease in the AchE activity in
serum of eserine, parathion, malathion,
atropine, and combination of atropine either
with eserine- or malathion-treated animals in
comparison to controls. The atropine
induced an even greater decrease (p < 0.05)
in such activity from 4.38 ± 0.2 U/mL in the
atropine-treated group to 1.32 ± 0.02 and
2.39 ± 0.2 when combined with the eserine
and malathion, respectively. 
Discussion 
Our study demonstrates that parathion and
malathion induced tumor formation in a
specific target organ, the mammary gland.
This is the ﬁrst report that organophospho-
rous pesticides induce changes in mammary
gland associated with carcinogenesis. Our
results showed that initiation occurs primar-
ily in the epithelium of TEBs while they are
developing into ABs because these structures
were affected by pesticides. This is an impor-
tant ﬁnding because such structures are con-
sidered equivalent to the terminal ductal
lobular unit described in the human breast
(9–13). Treatment with these substances
induced significant changes at a cellular
level. Forty-four-day-old animals showed a
significant increase in the density of TEBs,
inhibiting the normal process of differentia-
tion from TEBs to ABs that was seen in the
control animals. These results indicated that
the proliferative changes observed in the
TEBs may have induced the formation of
mammary adenocarcinomas. 
Breast tissue seems to be very sensitive to
ionizing radiation when exposure occurs
between the ages of 15 and 19 years (9),
which suggests that events that occur during
the early years of a woman’s life have a signif-
icant effect on lifetime risk of breast cancer.
An understanding of the mechanisms that
make the mammary glands of young women
more susceptible to carcinogenesis can be
achieved by using an adequate animal model
system. Previously, researchers (10,15) have
demonstrated that mammary carcinoma for-
mation in rats can be induced by a chemical
carcinogen, mainly DMBA, which seems to
provide such a model. Mammary tumors
thus induced were adenocarcinomas arising
from TEBs of incompletely differentiated
glands (10,12). The administration of
DMBA to virgin rats of different ages induced
tumors with an incidence that was directly
proportionally to the density of highly prolif-
erating TEBs (10). A tumor incidence of
94–100% was obtained when DMBA was
administered to rats 30–55 days of age, but
the highest number of tumors per animal was
observed when the carcinogen was given to
animals when they were 40–46 days of age, a
period when TEBs were most actively differ-
entiating into ABs. The high susceptibility of
the TEBs to neoplastic transformation is
attributed to the cell kinetic properties of its
lining epithelium, whose rate of cell prolifera-
tion is shown by DNA synthesis. The TEBs
were also characterized by having a high
growth fraction, proliferative fraction of the
cell cycle, which diminished in the more dif-
ferentiated ABs and lobules (9–13).
To determine whether cell kinetic para-
meters varied among the different compart-
ments of the breast in the human female and
whether they were affected by age and gland
topography (24), samples of normal human
breast tissue were studied in organ culture
systems. The results indicated differences
among the mammary glands of young and
old women. The correlation of different
parameters related to cell cycle determina-
tion indicated that values for growth fraction
and DNA synthesis or DNA-labeling index
were higher in the intralobular terminal
ducts and lower in alveoli and ducts. Studies
done on the influence of age and gland
topography on cell kinetics of normal
human breast indicated that both young and
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Table 3. Analysis of mammary gland tumor formation by the effect of eserine, parathion, malathion,
atropine, and combinations of eserine + atropine, parathion + atropine, and malathion + atropine in female
Sprague-Dawley rats treated from 39 to 44 days of age.
No. animals with Mean tumor size ± SE Mean latency ± SE
Treatment tumors/total animals  (cm3)a (days)b
Control (saline) 0/70 — —
Eserine (33 µg/100 g bw) 6/70 22.10 ± 7.20 488 ± 60
(5.4–49.56) (402–840)
Parathion (250 µg/100 g bw) 10/70 16.50 ± 5.60 569 ± 16
(2.5–45.00) (490–619)
Malathion (17 mg/100 g bw) 17/70 9.26 ± 3.43 (509 ± 45)
(0.08–42.30) (54–653)
Atropine (250 µg/100 g bw) 0/70 — —
Atropine + eserine 0/70 — —
Atropine + parathion  0/70 — —
Atropine + malathion 0/70 — —
aRange in tumor size. bRange of number of days before tumors appeared.
Figure 6. Histologic section of 44-day-old female rat mammary gland. (A) Histologic section of ABs of the
mammary gland from the control animal. The proliferative characteristics of TEBs in (B) eserine-, (C)
parathion-, and (D) malathion-treated animals are appreciated here. Hematoxylin-eosin, 400× .older women had the highest growth fraction
and DNA-LI in the intralobular terminal
ducts. The length of the cell cycle in these
structures increased from 200.3 to 847.0 hr in
the older women (24). The high rate of cell
proliferation was associated with the shortened
length of the cell cycle. Other reports (9–13)
have shown that DNA-LI among young virgin
rats was much higher than among old virgin
rats. The DNA-LI studies in young women
paralleled those results. The TEBs of young
virgin rats had a cell cycle of an average length
of 11 hr, lengthening to 21 and 28 hr in the
terminal ducts and ABs, respectively.
According to previous observations, the
susceptibility of the mammary gland to neo-
plastic transformation is related to its degree
of development and proliferative activity
(25). In vitro oncogenesis models of differ-
ent types of cells have yielded important
knowledge about the pathogenesis of neopla-
sia. Attempts to obtain transformation of
human breast epithelial cells in culture have
been also successful (25–27). Miyamoto et
al. (27) observed neoplastic transformation
of mouse mammary epithelial cells by in
vitro exposure to NMU. McCormick et al.
(28) reported neoplastic transformation of
epithelial cells by the effect of NMU in
mammary gland in vivo. The formation of
tumors observed in eserine-, parathion-, and
malathion-treated animals correlates with
the greater density of TEBs in the mammary
gland present in the 44-day-old treated
animals. The concomitant increase in the
area of ABs in the control animals and lack
of tumors in control animals allows corrobo-
ration of our results with what other groups
have found (12). 
Models for studying mammary carcino-
genesis have been developed in Sprague-
Dawley rats, with the chemical carcinogen
DMBA (15–17), which induced mammary
carcinomas in 100% of the animals with a
latency period of 86 days (15). Another
widely used experimental system to study
mammary tumorigenesis is the model in
which tumors are induced in the Fischer 344
rats by a single dose of NMU; such tumors
had latency similar to that observed by the
group mentioned above (18). In contrast to
these potent carcinogens, which induce
mammary carcinomas in 100% of intact
females (14), organophosphorous pesticides
seem to have a slow and less inﬁltrating and
potent effect. We observed that parathion
and malathion induced 14.3% and 24.3% of
mammary carcinomas, respectively. The
type of tumors observed had papillary ade-
nomatous patterns and ductal carcinomas
with cribiform pattern. 
Mammary tumors formed in various
strains of rats induced by chemical carcino-
gens or radiation have been classified by
several authors (9,14,29). There is agree-
ment that tumors appearing histologically
malignant in the rat have features in com-
mon with most frequently observed tumors
in humans. Intraductal and inﬁltrating duc-
tal carcinomas in the rat, unlike in the
human, constitute a minority of the tumors
developed under the commonly used
regimens for tumor induction. Most tumors
induced in young virgin rats can be classi-
fied within three major groups: intraductal
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Figure 7. Mammary gland tumors developed in the mammary gland region by the effect of (A) parathion
and (B) malathion in the female Sprague-Dawley rats. (C) Cross-sections of a papillary adenocarcinoma,
grossly nodular, encapsulated, with areas of cribiform or papillary patterns. It was removed after 84 days
of 5-day malathion treatment. (D) The histologic sections of another mammary tumor removed after 96
days of 5-day malathion treatment that revealed a ductal carcinoma. Hematoxylin-eosin, 400× .
Figure 8. (A) Cross-section of structures present in the mammary gland of a rat injected with atropine
(400× ). (B) Cross-section of ABs of a rat treated with the combination of atropine and pesticide.
Hematoxylin-eosin, 400× . 
Figure 9. Correlation between the density of TEBs
of the mammary gland and the AchE activity
(U/mL) present in the serum of 44-day-old control
and treated animals. The bars represent the mean
± SE of ﬁve animals per group. 
*p < 0.05 versus control; **p < 0.05 versus control.
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(U/mL)papillomas, composed of a hyperplastic
epithelium; papillary carcinomas, which may
be composed of epithelial cells with varying
degrees of cytologic atypia, growing in solid,
papillary adenomatous patterns; and ductal
carcinomas with cribiform pattern. All three
kinds of tumors were observed in the eser-
ine-and pesticide-treated animals. 
The density of TEBs was almost 4 times
greater, and the density of ABs was 10 times
lower in the pesticide-treated 44-day-old ani-
mals than in the control ones. Even though
the pesticides seem to act on undifferentiated
structures (i.e., TEBs), they also seem to have
a different mechanism of action, probably
through the inhibition of AchE that increases
Ach availability. For that reason, the inci-
dence of such tumors seems to be slower
through the inhibition of AchE than with the
direct-acting carcinogen DMBA. Our results
confirmed this interaction because 8.6% of
the animals treated with eserine also had
mammary gland tumors. 
Atropine alone did not induce changes
in the cell proliferation of mammary gland
of 44-day-old rats compared to the control,
whereas atropine induced inhibition in for-
mation of ABs compared to the controls.
However, the atropine treatment in con-
junction with either eserine or malathion
produced a decrease in the density of TEBs
and an increase in the formation of ABs sim-
ilar to control animals. On the other hand,
we also observed that atropine treatment
either alone or in combination with eserine
or malathion decreased three to five times
the AchE activity in the serum of animals,
compared to controls. The ABs reached the
normal development of the mammary gland
similar to the control animals, and there was
no tumor formation. The interesting ﬁnding
of these studies was that mammary tumors
were found only in the eserine-, parathion-,
and malathion-treated animals. Our experi-
ments indicated that the pesticides induced
AchE inhibition which remained for at least
3 months, suggesting that there was constant
cholinergic stimulation. It has been previ-
ously reported that animals treated with
AchE inhibitors presented a higher tolerance
to cholinergic agonists (5,6). Under normal
physiologic conditions, the cholinergic
receptors are usually operative through Ach
action, and atropine is known to occupy the
cholinergic receptors and interfere with the
action of Ach (5,6). Therefore, atropine may
inhibit the stimulatory effect of pesticides on
the Ach receptor. 
Previous work (30) has shown that a
single injection of isoproterenol increases
incorporation of thymidine into DNA of
salivary gland of rats and mice. This sub-
stance is a β -catecholamine adrenergic ago-
nist that is believed to induce chemical
changes in the cell membrane implicated in
the control of cell proliferation. Hypertrophy
and hyperplasia of parotid salivary gland has
been indicated by DNA synthesis. Other
reports (31) have indicated that reserpine, a
drug that alters the autonomic nervous sys-
tem by depleting the noradrenergic endings,
also induces remarkable changes in the sali-
vary gland. We have previously shown that
eserine, which acts on the autonomic nervous
system, can induce changes in DNA synthe-
sis of rat submandibular gland after a 5-day
in vivo treatment (32), which conﬁrmed the
proliferative effect of this substance. 
Parathion is highly toxic to mammals,
and the LD50 values in rats have been
reported to be 3.6 mg/kg, and the acute oral
LD50 values were 13 mg/kg (33,34). The
dosage of parathion in these studies was low
(250 µg/100 g bw); therefore, prolonged
exposure to low doses of pesticides may
eventually cause serious health effects in the
population. Among other factors that may
be involved with pesticide-induced mam-
mary carcinogenesis is the metabolism of the
organophosphorous insecticides, because
they can undergo a variety of metabolic
transformations in vivo and in vitro (35).
Thus, although the original insecticides are
poor inhibitors of AchE, the oxygen analogs
are several orders of magnitude more potent
in their inhibition of the target enzyme,
AchE. Benke and Murphy (36) have
reported pathways of metabolism that may
contribute to age differences in toxicity of
pesticides. A gradual decrease in the suscepti-
bility to toxicity by parathion with increas-
ing age was observed in rats. Because of
changes in the rates of reactions in the
detoxiﬁcation pathways for methyl paraoxon
and paraoxon rather than in the metabolism
of the original insecticides, the animals
became less sensitive to the acute effects of
these two substances with increasing age.
Brodeur and Dubois (37) found that wean-
ing rats 23 days old were more susceptible
than adult animals to organophosphorous
pesticides, implying that age is another fac-
tor in pesticide exposure.
We can conclude that the mechanism of
action of parathion and malathion occurs
probably through the inhibition of AchE, the
enzyme responsible for the hydrolysis of Ach
at cholinergic synapses (5,6) as it occurs with
eserine treatment. Thus, alterations at the
nervous system level seem to increase the
cholinergic stimulation and probably alter the
molecular pathways that initiate the prolifera-
tion leading to mammary carcinogenesis.
Because parathion and malathion have been
used extensively in Latin American countries
as well as in many other countries, these stud-
ies are relevant to understanding the possible
effects of these agents.
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